Ebru Canda

571 citations
55 papers · 326 indexed · h-index 9

Ebru Canda

45 papers receiving 317 citations

Peers

Ebru Canda
Comparison fields: 5 of 70
  • Clinical Biochemistry 77
  • Urology 41
  • Cell Biology 77
  • Rheumatology 56
  • Pediatrics, Perinatology and Child Health 45
Replace Maja Djordjevic with:
Maja Djordjevic Serbia
Lurdes Lopes Portugal
Hatae Maesaka Japan
Chuan‐Hong Kao Taiwan
Manuel Díaz-Llopis Spain
San‐Ging Shu Taiwan
Daniela Gaggioli Argentina
İlyas Okur Türkiye
Aria Setoodeh Iran
Shinji Nomura Japan
Ebru Canda relative to Maja Djordjevic Serbia Maja Djordjevic's profile →
Citations per field
00.5×1.7×
Maja Djordjevic · 1×
Citations per year

Countries citing papers authored by Ebru Canda

Since Specialization
Citations

This map shows the geographic impact of Ebru Canda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebru Canda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebru Canda more than expected).

Fields of papers citing papers by Ebru Canda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ebru Canda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebru Canda. The network helps show where Ebru Canda may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ebru Canda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ebru Canda Line = papers co-authored together Ebru Canda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20251
3 20242
4 20242
5 20230
6 20232
7 20220
8 20221
9 20221
10 202111
11 20217
12 20194
13 20183
14 20175
15 201727
16 20140
17 20144
18 20141
19 201012
20 201012

About Ebru Canda

Ebru Canda is a scholar working on Clinical Biochemistry, Biochemistry, Physiology, Rheumatology and Cell Biology, having authored 55 papers that have together received 326 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (18 papers), Lysosomal Storage Disorders Research (15 papers), Amino Acid Enzymes and Metabolism (9 papers), Diet and metabolism studies (5 papers), Cellular transport and secretion (5 papers), Mitochondrial Function and Pathology (4 papers), Neonatal Health and Biochemistry (4 papers) and Biochemical and Molecular Research (4 papers). The work is most often cited by research in Clinical Biochemistry (77 citations), Urology (41 citations), Cell Biology (77 citations), Rheumatology (56 citations) and Pediatrics, Perinatology and Child Health (45 citations). Ebru Canda has collaborated with scholars based in Türkiye, Switzerland and Germany. Frequent co-authors include Sema Kalkan Uçar, Mahmut Çöker, İpek Akil, Hüseyin Önay, Ayten Egemen, Beyhan Cengiz Özyurt, Erhan Eser, Ferda Özkınay, Havva Yazıcı and Melis Köse. Their work appears in journals such as Pediatric Nephrology, Blood Cells Molecules and Diseases, European Journal of Clinical Nutrition, European Journal of Medical Genetics and Journal of Bone and Mineral Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026